Lisa Shantz

Dr. Lisa Shantz


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SKScot R Kimball
Scot R Kimball
LSLisa Shantz
Lisa Shantz
RHRick L. Horetsky
Rick L. Horetsky
LJLeonard S. Jefferson
Leonard S. Jefferson
Regulation of translation of mRNAs coding for specific proteins plays an important role in controlling cell growth, differentiation, and transformation. Two proteins have been implicated in the regulation of specific mRNA translation: eukaryotic initiation factor eIF4E and ribosomal protein S6. Increased phosphorylation of eIF4E as well as its overexpression are associated with stimulation of translation of mRNAs with highly structured 5′-untranslated regions. Similarly, phosphorylation of S6 results in preferential translation of mRNAs containing an oligopyrimidine tract at the 5′-end of the message. In the present study, leucine stimulated phosphorylation of the eIF4E-binding protein, 4E-BP1, in L6 myoblasts, resulting in dissociation of eIF4E from the inactive eIF4E·4E-BP1 complex. The increased availability of eIF4E was associated with a 1.6-fold elevation in ornithine decarboxylase relative to global protein synthesis. Leucine also stimulated phosphorylation of the ribosomal protein S6 kinase, p70S6k, resulting in increased phosphorylation of S6. Hyperphosphorylation of S6 was associated with a 4-fold increase in synthesis of elongation factor eEF1A. Rapamycin, an inhibitor of the protein kinase mTOR, prevented all of the leucine-induced effects. Thus, leucine acting through an mTOR-dependent pathway stimulates the translation of specific mRNAs both by increasing the availability of eIF4E and by stimulating phosphorylation of S6.

1 January 1987 in Advances in Enzyme Regulation
Verified
Journal Article
Closed access
GGGary B. Gordon
Gary B. Gordon
LSLisa Shantz
Lisa Shantz
PTPaul Talalay
Paul Talalay

1 January 1995 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
APAnthony E. Pegg
Anthony E. Pegg
LSLisa Shantz
Lisa Shantz
CCCatherine S. Coleman
Catherine S. Coleman

1 January 1999 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
LSLisa Shantz
Lisa Shantz
APAnthony E. Pegg
Anthony E. Pegg

19 April 2007 in Amino Acids
Verified
Journal Article
Closed access
PDF file
LSLisa Shantz
Lisa Shantz
VLV. A. Levin
V. A. Levin

1 November 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HRHangjun Ruan
Hangjun Ruan
LSLisa Shantz
Lisa Shantz
APAnthony E. Pegg
Anthony E. Pegg
DMDavid R. Morris
David R. Morris
S-Adenosylmethionine decarboxylase (AdoMetDC) is a key enzyme in the pathway of polyamine biosynthesis. The cellular levels of the polyamines specifically regulate AdoMetDC translation through the 5′-leader of the mRNA, which contains a small upstream open reading frame (uORF) 14 nucleotides from the cap. Mutating the initiation codon of the uORF, which encodes a peptide product with the sequence MAGDIS, abolished regulation. In addition, the uORF is sufficient, by itself, to provide polyamine regulation when inserted into the 5′-leader of the human growth hormone mRNA. Changing the amino acid sequence at the carboxyl terminus of the peptide product of the uORF abolished polyamine regulation. In contrast, altering the nucleotide sequence of the uORF at degenerate positions, without changing the amino acid sequence of the peptide, did not affect regulation. Extending the distance between cap and uORF, thereby changing the rate of initiation at the initiator AUG of the uORF, did not alter polyamine regulation. When the uORF was extended so as to overlap, out of frame, the downstream major cistron, polyamine regulation was abolished. We propose that polyamines do not modulate the rate of recognition of the uORF but rather regulate interaction of the peptide product of the uORF with its target.